Literature DB >> 7002388

Relationship between HLA-D and in vitro and in vivo responsiveness to Candida allergen.

Y Nose, K Komori, H Inouye, K Nomura, M Yamamura, K Tsuji.   

Abstract

In vitro reaction to Candida allergen was studied in 100 normal healthy Japanese and related to HLA. A significant association was found between the low responder group (< 7,000 c.p.m.) and HLA-B15 and the high responder group (> 7,000 c.p.m.) and HLA-B7, as well as Dwl. Four HLA-D homozygote cells of types HLA-Dwl and DHO, were tested; these fitted in the high responder group. HLA-DYT and DEn fitted into the low responder group. Responsiveness to Candida allergen corresponded to skin test (r = 0.884, P < 0.01). From these results, in vitro lymphocyte reaction to Candida allergen and skin tests showed close correlation and an association with HLA antigens, HLA-D in particular.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002388      PMCID: PMC1536975     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Association of the HL-A7 cross-reacting group with a specific reaginic antibody response in allergic man.

Authors:  D G Marsh; W B Bias; S H Hsu; L Goodfriend
Journal:  Science       Date:  1973-02-16       Impact factor: 47.728

2.  Antigenic activity of the cell components of Candida albicans.

Authors:  A Tomsíková; D Vsikl; D Novácková
Journal:  Mykosen       Date:  1976-06

3.  Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.

Authors:  T Sasazuki; Y Kohno; I Iwamoto; M Tanimura; S Naito
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

4.  Candida albicans antibodies in candidiasis.

Authors:  P L Andersen; A Stenderup
Journal:  Scand J Infect Dis       Date:  1974

5.  The relationship between HLA-D and DR antigens in four Japanese HTCs.

Authors:  K Tsuji; Y Nose; K Komori; Y Shiwaku; H Inouye
Journal:  Transplant Proc       Date:  1978-12       Impact factor: 1.066

6.  National gonorrhea therapy monitoring study: treatment results.

Authors:  R E Kaufman; R E Johnson; H W Jaffe; C Thornsberry; G H Reynolds; P J Wiesner
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

7.  Ragweed hay fever: genetic control and linkage to HL-A haplotypes.

Authors:  B B Levine; R H Stember; M Fotino
Journal:  Science       Date:  1972-12-15       Impact factor: 47.728

8.  Antibodies to Candida albicans in hospital patients with and without spinal injury and in normal men and women.

Authors:  P H Everall; C A Morris; D F Morris
Journal:  J Clin Pathol       Date:  1974-09       Impact factor: 3.411

9.  Genetic control of the antibody response in inbred mice. Transfer of response by spleen cells and linkage to the major histocompatibility (H-2) locus.

Authors:  H O McDevitt; M L Tyan
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

  9 in total
  5 in total

Review 1.  Recurrent genital tract infection: a result of induced immunosuppression?

Authors:  C Sonnex
Journal:  Genitourin Med       Date:  1989-12

2.  Specific immune responses after booster immunization with tetanus toxoid in man: study of kinetics, family segregation, and linkage to HLA of in vitro lymphocyte proliferative responses and serum-antibody responses.

Authors:  J J Ballet; C Rabian-Herzog; M Lathrop; J F Bourge; M Agrapart; J Drouet; J M Lalouel; J Dausset
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man.

Authors:  N Ohta; Y K Nishimura; M Iuchi; T Sasazuki
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

Review 4.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

5.  Role of macrophages in T lymphocyte response to Candida allergen in man with special reference to HLA-D and DR.

Authors:  Y Nose; K Komori; H Inouye; K Nomura; M Yamamura; K Tsuji
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.